Roche’s $7.1 Billion Acquisition of Telavant

Davis Polk & Wardwell is advising Roche on the transaction, and Freshfields Bruckhaus Deringer is advising Roivant.Roivant (Nasdaq: ROIV) announced it has entered into a definitive agreement…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

This content is for Standard 1 Year members only.
Login Join Now